Myriad Genetics Inc
Diagnostics & Research
Healthcare
MYGN
91.40 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
7.91
52 week high
28.60
high
8.04
52 week low
0.00
previous Close
7.84
P/E ratio
market cap
361 M
div yield
0
net profit margin
0.00 %
0.00 %
operating incoming
0.00 %
net change in cash
0.00 %
top